Tablet Formulation Design A
Tablet Formulation Design A
Q Abstract
Tablet is the most preferred oral dosage form, due to many advantages it offers to formulators as well as physicians and patients.
However, the process of manufacturing tablets is complex. Hence, careful consideration has to be given to select right process,
and right excipients to ultimately give a robust, high productivity and regulatory compliant product of good quality.
Dose Low dose may have content uniformity effects. Misoprostol, ramipril - low dose.
High dose may result in direct physical impact of the API on tablet Metformin, paracetamol - high dose.
roperties.
Solubility Low solubility of API may dictate the choice of manufacturing process Nifedipine, gliclazide have low solubility.
from dissolution point of view. A wet granulation is the preferred method
with such API.
Melting point Low melting point of API may result in sticking problems or Ibuprofen (M.P. ~ 560 C) is known to
soft tablets during compression. cause tablet punch sticking.
Particle size Lower particle size of API may be important for higher solubility and Celecoxib, Albendazole.
dissolution. However, this may give rise to capping problem in tablets.
pKa It dictates the pH level at which ionization takes place and subsequent Aspirin, meloxicam exhibit better
solubilization. Acidic API having pKa (3-5) will solubilize at higher pH. solubility in basic pH.
Flow properties Poor flow of API may lead to loss of tablet hardness and weight variation Paracetamol bulk powder has poor flow.
issues. This may restrict the formulator to use granulation techniques or Hence needs to be granulated for tablet
higher levels of lubricants/glidants to impart the flow, which may preparation.
adversely affect dissolution and compaction.
Bulk density Density plays a significant role in the blend uniformity of API along Glucosamine sulphate has high bulk
with other excipients. In general, for a high density API, the diluent density, whereas Chondroitin sulphate
selected should have high density and vice-versa in order to avoid has low bulk density.
segregation issues in a directly compressible formulation.
Moisture content High moisture content of API may result in sticking issues during Ampicillin trihydrate formulation often
compression of tablets. cause tablet punch sticking problem.
Hygroscopicity Highly hygroscopic API may result in problems such as tablet punch Divalproex sodium and L-Carnitine.
sticking. Careful selection of manufacturing process, low humidity
conditions in processing area become critical for such API.
Polymorphism Certain API exhibit polymorphic forms, which may have differences Desloratadine, Clopidogrel
in solubility, chemical stability or bioavailability. The polymorphic
trans formation may occur during manufacturing process due
to application or generation of heat or presence of moisture.
Degradation Certain API are unstable to heat or moisture or light. Formulating Nifedipine is photosensitive.
profile such API into tablets may be challenging. Rabeprazole is sensitive to heat and
moisture.
Excipient Certain API may be incompatible with specific excipients and may Aspirin is incompatible with
compatibility limit their selection. Excipient compatibility testing would help in magnesium stearate, Primary amine
selecting right excipient. based API's are incompatible with
Lactose (due to Malliard's reaction)
Compactability Good ability to compact renders ease in direct compression of Acetaminophen has poor ability to
tablets. Certain API's, however, have poor ability to compact and compact, whereas Aspirin is good.
hence granulation techniques may be required as a means
of formulation velopment.
Secondary excipients - This includes; film coating, colors, flavors, sweeteners, wetting agents. These excipients are responsible for
appearance and performance.
Q Diluents
Diluent is added to formulation to increase the bulk volume of the active and hence the size of the tablet suitable for handling. The
selection of the diluent will depend on the type of processing and plasticity of materials to be used. In general, a direct-compression formulation
will require a diluent with good flow and compaction properties. Table 3 lists some of the commonly used diluents.
Lactose z Lactose deforms by brittle fracture. z Lactose intolerance. z Available as anhydrous and
z Less sensitive to Mg. stearate z Bovine derived. monohydrate; anhydrous material
over blending. z Abrasive - requires high levels used for direct compression due
z Less sensitive to press speed. of lubricant. to superior compressibility.
z Granulation does impart some z May brown on aging/Maillard
plastic nature to the end product. reaction.
z Good compressibility. z Slowest dissolving sugar -
z Soluble in water. formulations need adequate
z Many different grades available. disintegrant.
z Spray dried forms may contain
amorphous material.
Mannitol z Non-hygroscopic. z Very abrasive. Requires high levels z It is not a reducing sugar and can be
z Partly soluble in water. of lubricant. substituted for lactose (lactose not
z Non reactive. z Can cause punch filming/ picking. acceptable in certain markets).
z Negative heat of solution - z Potential laxative effect at high dose. z 10 - 90% usage level.
cooling mouth feel. z Expensive.
z Many grades available. z Has both plastic and brittle nature
depending on grade.
Sucrose z Sucrose serves as a dry binder z Powdered sucrose is a cohesive solid. Sucrose is also available as invert
(2-20% w/w) or as a bulking agent z Tablets that contain large amounts sugar, compressible sugar and
and sweetener in chewable tablets of sucrose may harden over time to as sugar spheres.
and lozenges. give poor disintegration.
z Crystalline sucrose is free flowing.
Partial z Has better compaction properties z For direct compression, it may be z Can be used up to 75% in
pregelatinized than native starch. advantageous to combine partial wet granulation.
starch z Partial gelatinization improves pregelatinized starch with MCC or z Can be used up to 50% in
binding yielding, improved granule lactose in a 1:1 ratio for enhancing direct compression.
strength and enhanced tablet tablet hardness. z Globally accepted.
hardness.
z Multifunctional - acts as binder and
disintegrants.
z Self lubricant and reduces
requirement of lubricants.
Dicalcium z Excellent flow properties. z Practically insoluble in water, soluble z Not used extensively in
phosphate z Ability to compact is good and in acid but not alkali. wet granulations.
independent of machine speed. z Not recommended for use with z Deforms by brittle fracture.
z Less susceptible to Mg. stearate poorly soluble API. z Used up to 50%.
over-blending. z Loses water of crystallization at z Available in milled and
z Non-hygroscopic. elevated temperatures. unmilled forms.
z Can "trap" API under a cone or heap
in a dissolution vessel.
z Abbrasive - can cause accelerated
tooling and machine wear.
Diluents form a major portion of most of the tablet formulations tablet press, key process and corresponding diluent knowledge has
due to newer high potency API's. The moisture content, more become important. Use of combination of diluents with synergistic
specifically water activity coefficient of such diluents, may influence properties or co-processed excipients, such as StarCap 1500®, co-
API stability since many API are prone to degradation by hydrolysis. processed starch excipient, are gaining significance in the
In general, moisture content may indicate hydrate form or tightly pharmaceutical industry. Figure 2 shows impact of tablet press
bound water molecule of crystallization, or surface-bound or surface- speed on the tablet breaking force (hardness) when compressed at
absorbed water on the excipient. The bound water may not cause increasing compression pressure. It can be seen that formulation
hydrolysis of sensitive API, but free- or surface- absorbed water may with combination of MCC + Starch 1500 gives low yet acceptable
be responsible for hydrolysis of sensitive API. This free water is hardness of tablets when compressed at higher speeds and at high
termed as water activity coefficient. Figure 1 gives loss on drying compression pressures. This also means that the disintegration time
(LOD) and water activity coefficient of some commonly used filler. is not affected for tablets compressed at higher compression pressure
Lactose, for instance, has low LOD, but very high water activity
coefficient. On the other hand, Starch 1500 has very high LOD, but
very low water activity coefficient. Hence, for API such as Aspirin or
Ranitidine that undergo hydrolysis, Starch 1500 provides stable
formulation, whereas lactose or plain microcrystalline cellulose leads
to higher impurity levels on stability (Cunnigham CR 2001).
Tablet Breading Force (kp)
Mositure content
Native starch paste 5 - 25 z Good binding ability. z Time consuming process, high
variability in preparation of
starch paste.
Pregelatinized starch 5 - 10 z Cold water soluble, so easier to prepare z Only functions as a binder.
than starch. The formulations with pregelatinized
starch require separate
disintegrating agents.
Partially 5 - 15 z Acts as binder and also as disintegrant. z Different suppliers have different
pregelatinized z Acts as a multifunctional agent. gelatinization level.
starch
Polyvinylpyrrolidone 2-8 z Available in range of molecular z Gives harder tablets upon stability
weight/ viscosities. prolonging the disintegration time
z Soluble in water and ethanol. and dissolution of the active.
Hydroxypropyl 2-8 z It is soluble in different solvent systems z May give hard granules especially if
methylcellulose and suitable for both aqueous, binder concentration and kneading
non-aqueous or hydro-alcoholic solvents. time is increased, during high
z Can be used for modulation of shear granulation.
API release.
z Number of viscosity grades available for
granulation.
Disintegrant is included in the Alginic acid, 4-6 Swells like gums, but forms less viscous gels than
formulation to ensure that the tablet breaks sodium alginate guar gum, xanthan, etc.
up into small fragments in contact with liquid.
Figure 4 shows influence of disintegrating Crospovidone 1-5 High wicking activity.
agent on disintegration time of tablets.
Tablets must have sufficient strength to immediate release preparations. To powerful disintegrating agents
withstand the stresses of subsequent overcome the cohesive strength produced (superdisintegrants), such as croscarmellose
manufacturing operations, such as the by the compression process, and to break sodium, sodium starch glycolate,
coating, packaging, and distribution process. down the tablet into the primary particles as crospovidone and certain ion exchange
However, once the tablet is taken by the rapidly as possible, disintegrants are added resins, which display excellent disintegration
patient, it must break up rapidly to ensure to the tablet formulations. The positioning activity at low concentrations than native
rapid dissolution of the active ingredient in of disintegrants within starches. Major limitations of these
the intra- and extra- superdisintegrants are relatively high cost
granular portions of and hygroscopic nature, which could
granulated formulations negatively affect the stability of moisture
can affect their water sensitive API (if the packaging does not
uptake and provide adequate protection from the
disintegration time. environment). Figure 5 depicts the moisture
Table 5 gives list of vapor sorption graph for different
some disintegrants disintegrants (Cunnigham CR, 1999).
commonly used in tablet Superdisintegrants, such as crospovidone,
formulations.
sodium starch glycollate and croscarmellose
Starch was the first sodium, in general, have high moisture
disintegrant used in sorption tendency., Therefore, sometimes
tablet manufacture. The unsuitable for formulations containing
compaction properties of moisture sensitive or hygroscopic API.
many disintegrants, Higher concentration of such
including native starch, superdisintegrants also causes problems
are not satisfactory and during aqueous film coating, often giving rise
use of high to orange peel effect to the coating.
Figure 4: Effect of different disintegrants on the physical properties concentration can also
of Hydrochlorthiazide tablets Most pharmacopeias include a disintegration
reduce tablet strength.
test which can be applied to tablets and the
(Tablet are composed of Hydrochlorthiazide, Dicalcium Recent trend in
Phosphate, Lactose spray dried, magnesium Stearate and pharmaceutical industry detailed monograph is given in the
disintegrants) is towards use of pharmacopeias.
Q Anti-adherent
% Relative Humidity at 25 deg. C
Anti-adherent causes reduction in
Figure 5: Moisture uptake isotherms for powders of different disintegrating agents. adhesion of powder to punch faces and thus
Q Other excipients
Certain excipients, like anti-oxidants and surfactants, are used
only in situations where they are expressly needed to ensure the
stability or performance of the product.
Q Excipient selection
The selection of excipients is influenced by range of interrelated
factors, both objective and subjective. All the factors, like properties
Properties of excipients
z Stablity (chemical & physical)
z Hygroscopic
z Compatible
Figure 7: Effect of Magnesium Stearate on Dissolution of z Particle size
Hydrochlorthiazide z Availability
z Cost
z Regulatory acceptance
helps in preventing sticking. These materials
do not influence ejection force or residual
force. Thus they are most often used in Properties of drug
Manufacturing process
combination with other lubricants to improve z Dose
overall performance during compaction. z Solubility/ pKa
Selection of requirement
z Direct compression
z Particle Size/ Shape excipients for z Wet granulation
Magnesium stearate, a boundary wall z Melting Point/ Thermal
lubricant, readily forms a thin film on the die- Stability
solid oral z Fluid bed granulation
z Spray drying
wall surface. This results in reduction in z Flow Properties dosage forms z Extrusion &
powder ability to form strong compacts. Also, z Densities
due to hydrophobic nature, it can hinder spheronization
disintegration and dissolution performance z Other novel process
UK company Paraytec has introduced a drug to come to market, thereby offering used in a number of other applications in the
a new instrument designed to allow significant potential gains in earnings," pharmaceutical industry, including enzyme
formulation scientists to visualise - in real according to a Paraytec statement. assays and protein sizing. Paraytec has also
time - what is happening at a tablet surface been developing the technology for in-line
Tablet holder enables accurate analysis
when it dissolves. testing in bioprocessing, for example by
The instrument combines a specially quantifying protein aggregation.
The new device - called the ActiPix
designed tablet holder and Paraytec's ActiPix
Dissolution Imager - was introduced to the Paraytec spun of from University of York
D-100 UV area imager. The holder is placed
marketplace at Pittcon on March 9 and could Paraytec was spun out from the
inside the ActiPix D-100 which enables real
make it easier for drug developers to develop University of York to develop a series of
time recording and review of data. When
controlled-release medications. instruments based on miniaturised
liquid flows over the surface of the
formulation, release of the active ingredient ultraviolet-visible (UV-vis) absorbance
Paraytec says the instrument offers
can be quantitatively monitored directly at the detectors and capillary-based fluid handling
formulation scientists an alternative to "high-
tablet surface. technology.
cost, complex techniques such as terahertz
spectroscopic imaging and magnetic UV absorbance detection is a laboratory
"It is important ... to understand the
resonance imaging "as they investigate the technique widely employed to characterise
mechanism of drug release behaviour, as this
release of active compounds from dosage and determine the levels of substances which
regulates the performance of many solid
forms. dissolve in water and other liquids, with light
pharmaceutical dosage formulations," said
absorbed at different wavelengths in the
The ActiPix Dissolution Imager is "a Paraytec.
ultra-violet region indicating different
powerful tool that can reduce the time it takes
The ActiPix D-100 instrument has been compounds.